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Abstract— Non-steroidal anti-inflammatory drugs 
(NSAIDs) are now one of the most frequent drugs used in 
treatment of pain, inflammation and fever. In this study the 
aim is the synthesis of derivatives of    4-Tiazolidinon from 
naproxen with the possible anti-pain effects, and the main 
purpose of providing these derivatives is to achieve a 
compound with more anti-pain power and less side effects 
in comparison with applied drugs in clinics. Synthesis of 
these derivatives is done on chloride in presence of a 
group of new liquids like recyclable ionic liquids choline 
chloride, which the main advantages of these ionic liquids 
are the cheapness, availability, being non-toxic, and easy 
recyclability. This reaction was done in four stages. All the 
structures were verified by using data of spectrum testing, 
1H-NMR, FT-IR.     
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I. INTRODUCTION 
To date, Nonsteroidal anti-inflammatory drugs (NSAIDs) 
are known as one of the most commonly used drugs for 
treatment of pain, inflammation, and fever [1]. Despite the 
abundant clinical usage of these types of drugs, some 
drawbacks including digestive and renal complications 
encourage scientists to design and synthesize new pain-
relievers [2, 3]. In this study, we aimed the synthesize of 4-
thiazolidinone derivatives from naproxen with probable 
analgesic and anti-inflammatory effects. The main goal is 
the development of new compounds with more therapeutic 
effects and less side-effects respect to common 
medications in clinics. Generally, one of the biggest 
problems for using of NSAIDs is their side-effects, which 
is mainly due to rising leukotriene levels at inhibition of 
cyclooxygenase enzyme and leading arachidonic acid to 
the lipoxygenase pathway.[4] On the other hand, 
generation of free oxygen derivatives such as superoxide 
anions through reduction of oxygen provokes producing 
other activate molecules like hydrogen peroxide (H2O2) 
and hydroxyl radicals. Interference with arachidonic acid 
causes chemotactic materials production which continues 
inflammation.[5,6] To diminish the side-effects of anti-
inflammatory drugs, synthesis of 4-thiazolidinone 
heterocyclic compounds was investigated based on various 
reports about their anti-inflammatory effects. 4-
thiazolidinone derivatives compounds show higher anti-
inflammatory effects but lower side-effects than 
conventional drugs.[7] Implying analgesic and anti-
inflammatory effects of N-aryl hydrazone naproxen in 
previous researches, hybrid compounds from 4-
thiazolidinone and N-aryl hydrazone naproxen were 
developed to investigate their pharmacological studies for 
anti-inflammatory and pain-relieving effects as well as 
their digestive complications related to commonly used 
drugs.[9,10] These compounds were synthesized via 
previously reported methods and general procedures. 
Chemical structures of the intermediates and final products 
were confirmed using 1HNMR, 13CNMR, and IR 
spectroscopy.  
 
II. EXPERIMENTAL SECTION 
2.1. General Methods: 
All reaction were monitored by "TLC" on pre-coated silica 
gel plates (60 F 254:Merck) column chromatography was 
performed on 100-200 mesh silica gel (SRL,India) using 
10-20 fold execess (by weight) of the crude product. 
IR spectra were recorded on a shimadzu FTIR 300 
spectrometer in KBr pellets. Melting points were all 
determind by open glass capillary method on a melting 
point apparatus and are uncorrected. All used chemical or 
solvents were purchased from standard commercial 
suppliers (sigma Alderich and merck) and used as received 
without further purification. 1H and 13C NMR spectra were 
recorded on a bruker ACF-300 machine or a varian 300 or 
400 MHZ spectrometer using either DMSO-d6 as a solvent 
with tetramethylsilane as internal refrence [11]. 
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2.2. Preparation of Intermediates (I)-(IV)  
2.2.1. Synthesis of 2-(6-metoxy-naphthalene-2-yl) ethyl 
propanionate: 
To a solution of 2-(6-methoxy-naphtalen-2-yl) propionic 
acid methyl ester (500 mg, 0.01 mol) in ethanol (20 ml) 
was added a few drops of conc.H2SO4 dropwise and the 
mixture was stirred at 85-90 oC for 12 h. After the 
completion of the reaction (indicated by TLC) ethanol was 
treated with water [12], The separated solid was filtered 
and dried to give the desired product as a colorless salid 
(yield .96%) mp 104-106 oC- 1H-NMR (400 MHz, DMSO-
d6): , 7.78-7.69 (m, 3H, ArH), 7.45 (dd, J = 8.3 and 1.6 
Hz, 1H), 7.25-7.24 (m. 1H), 7.13(dd, J=8.8 and 2.5 
Hz,1H), 4.21(q, 2H, J=6.4 Hz), 3.86(s. 3H, OMe), 3.66 (q, 
1H, J=6.4 Hz), 1.59 (d, 3H, J=5.7 ), 1.21 (t, 3H, J=5.9 ); 
FT-IR (KBr, cm-1) 3310,3250, 2979, 2939, 1656, 1623. 
 
2.2.2. Synthesis of 2-(2- metoxy naphtalen-6-yl)propan 
hydrazide: 
To a solution of 2-(6-metoxy naphtalen-2-yl) propanionate 
(1mmol-0.23g) in ethanol (5ml) was added hydrazine 
hydrate (3.0 ml) with vigorous stirring at room 
temperature. The mixture was then stirred at 85-90 oC for 
12h [12]. After completion of the reaction (indicated by 
TLC) ethanol was treated with water [12], The separated 
solid was filtered and dried to give the desired product as a 
colorless salid (yield .78%) mp 110-1112 oC-FT-IR (KBr) 
νmax (cm-1): 3284 (NH), and 3093 (CH-aromatic),2998, 
2971, 1672 (C=O, keton), 1489 (C=C), 1091(C-C). 
1HNMR (DMSO-300MHz) δ ppm: 9.99 (s, 1H, NH, D2O 
exchangeable); 9.20 (s, 1H, NH, D2O exchangeable); 7.23-
7.93(m,4H, Ar-H), 7.24 (s, 1H, Ar- H), 383 (3H, s, OCH3), 
3.63(1H, q, J=5.4), 1.59 (3H, d, J= 5.85), 2.11 (s, 3H, 
CH3). 
 
2.2.3. General method for synthesis of 1-arylidene-2-(3-
(6-methoxynaphthalen-2-yl) but-1-en-2-yl)hydrazine: 
To a solution of 2-(2- metoxy naphtalen-6-yl)propan 
hydrazide (500 mg, 0.01 mol) in dichloromethan (20 ml) 
was added zinc chloride (0.1 g) and derivatives of 
aldehyde (1 mmol) and the mixture was stirred at 85-90 oC 
for 12 h. After the completion of the reaction (indicated by 
TLC) ethanol was treated with water [12], The separated 
solid was filtered and dried to give the desired product as a 
white solid; Yield 91%, m.p: 150-160˚C; FT-IR (KBr, cm-
1); 3329 (N-H), 3214 (C-H), 1680 (C=O), 1605 (C=N); 
1524 (C=C);; 1242 (C-N). 1HNMR (DMSO, 300MHz) δ 
ppm: 12.18(s, 1H, NH, brs), 7.82-8.16 (m, 4H, Haromatic), 
7.69 (s, 1H, C=CH), 6.51-7.39 (m, 4H, H aromatic), 3.71(s, 
3H, OCH3). (Scheme 1) 
 
2.2.4. Synthesis of 2-(6- metoxy naphtalen-2-
yl)propanoil)-propamido-N-(2-hydroxy phenyl)-6-
mercapto-thiazolidine-4-one: 
To a solution of 1-arylidene-2-(3-(6-methoxynaphthalen-2-
yl)but-1-en-2-yl)hydrazine (1mmol) in dichloromethan 
(5ml) and zinc chloride (0.1 g) was added 2,2-
dithiopropanoic acid (1mmol) with vigorous stirring at 
room temperature. The mixture was then stirred at 85-90 
oC for 6h. Yield 78%, m.p 110-120 °C. FT-IR (KBr) νmax 
(cm-1): 3233 (NH), and 3093 (CH), 1672(C=O), 1489 
(C=C), 1091(C-C), 1HNMR (DMSO-300MHz) δ ppm: 
9.99 (s, 1H, NH); 7.23-7.93 (m,4H, Ar-H); 7.24(s, 1H,Ar- 
H); 2.11-2.27(s, 3H, CH3). 
 
2.3. Antibacterial Activity: 
To examine the antibacterial activity of some synthesized 
compounds, one gram negative bacteria: Escherichia Coli 
(ATCC, 6538). One gram positive bacteria: 
Staphylococcus Aureus (ATCC, 25922), were selected and 
tested by the disc diffusion method [15] using Mueller–
Hinton Agar against. Tetracycline was used as standard. 
Normal saline was used for preparation of inoculants 
having turbidity equal to 0.5 McFarland standards. Tested 
compounds were dissolved in dimethyl sulfoxide (DMSO) 
for the preparation of stock solution. The solvent control 
was included, although no antibacterial activity has been 
noted. Culture was carried out with sterile swab and 
microtube suspension was cultured for 24 h and then 
inoculated onto Mueller Hinton agar. Blank discs with a 
diameter of 6 mm and containing 30 μg of the 
concentration of these compounds (D3) were placed on 
Muller Hinton agar medium. 
After 24 h incubation at 37 °C, area of growth inhibition 
was measured. Disks containing 10 μg of 5 dimethyl 
sulfoxide were used as the negative control. Each 
concentration was repeated 4 times for each of the bacteria 
and the average results of inhibitory effects are show in 
Table 1. 
Determination of the minimum inhibitory concentration 
(MIC) values for some synthesized compounds against six 
microorganisms was carried out using disc diffusion 
method. In this method, concentration of 10, 20, 30, 50, 
150 μg /mL were used for all bacteria per disc and there 
were incubated at 37 °C for 24 h. MIC value was defined 
as lowest concentration of compound for inhibition growth 
of the tested bacteria. 
3. Results & discussion: 
In this study in the presence of deep eutectic solvent as 
environmentally friendly catalyst and reaction medium, 
synthesize of some thiazolidine-4-one derivatives from 
naproxen has been discussed (scheme2). This reaction was 
more efficient in good yield in short time duration. Finally, 
after completion the reaction, that's possible to separate the 
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catalyst. The results led to the synthesis of 3-(2-(2- metoxy 
naphtalen-6-yl)propanoil)-1,3,4 tiadiazolidin-2-ones 
substances with possibly particular biological and 
medicinal properties. The structure of synthesized 
compounds (f-g) was confirmed by FT-IR, 1H-NMR, 13C-
NMR spectroscopic methods. All the physical, chemical 
properties, IR, NMR of the compounds are reported in 
experimental parts. All the compounds display 
antibacterial effect against Gram positive bacterias, S. 
aureus, and E. coli Gram negative bacteria. Specifically, 
the synthesized compounds screened for their biological 
study which displayed moderate to good activity.  
 
 
Scheme1: General method for the synthesis of 1-
benzylidene-2-(3-(6-methoxynaphthalen-2-yl)but-1-en-2-
yl)hydrazine 
 
            
 m.p(OC)  
  
Yiel
d 
(%) 
 
Time(h
r) 
 
 
R= aldehyde 
 
Ent
ry 
 
 
157-159 
 
 
95 
 
 
 
6 
 
 
1 
 
182-185 
 
90        
 
3 
 
 
2 
 
 
160-162 
 
 
70 
 
 
3 
 
 
 
3 
 
 
170-172 
 
80   
        
 
4 
 
 
4 
 
 
190-193 
 
40   
       
       
     
 
3 
 
 
5 
 
200-202 
 
50 
 
3 
 
 
 
6 
Table 1. Synthesis of some 2-(6- metoxy naphtalen-2-
yl)propanoil)-propamido-N-(2-hydroxy phenyl)-6-
mercapto-thiazolidine-4-one with some aldehydes 
 
 
Scheme 2: Synthesis of some 2-(6- metoxy naphtalen-2-
yl)propanoil)-propamido-N-(2-hydroxy phenyl)-6-
mercapto-thiazolidine-4-one in the presence of some 
aldehydes 
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